| (Values in U.S. Thousands) | Aug, 2024 | May, 2024 | Feb, 2024 | Nov, 2023 | Aug, 2023 |
| Sales | 3,080 | 3,150 | 3,170 | 3,890 | 3,300 |
| Sales Growth | -2.22% | -0.63% | -18.51% | +17.88% | +0.30% |
| Net Income | 5,000 | -13,740 | -2,750 | -4,680 | -3,160 |
| Net Income Growth | +136.39% | -399.64% | +41.24% | -48.10% | -110.67% |
Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Fiscal Year End Date: 08/31